These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7609185)

  • 21. Use of injectable fat to obstruct the urethra in rabbits.
    Canning DA; Seibold J; Saito M; Zderic SA; Snyder HM; Duckett JW; Levin RM
    Neurourol Urodyn; 1995; 14(3):259-67. PubMed ID: 7647808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Submucosal bladder neck injection of bovine dermal collagen for stress urinary incontinence in the pediatric population.
    Pérez LM; Smith EA; Parrott TS; Broecker BH; Massad CA; Woodard JR
    J Urol; 1996 Aug; 156(2 Pt 2):633-6. PubMed ID: 8683748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of autologous fat implantation in the rat urinary bladder submucosa.
    Olson ME; Morck DW; Ceri H; Lee CC; Chancellor MB
    Urology; 1998 Nov; 52(5):915-9. PubMed ID: 9801130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ordinary glass spheres as an alternative injectable material for endoscopic correction of vesicoureteral reflux.
    Simsek F; Yucel S; Aktas M; Turkeri L
    J Urol; 2004 Mar; 171(3):1282-6. PubMed ID: 14767333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does technique or material used affect bladder tissue reactions when injecting teflon or silicone paste?
    Smith DP; Beegle BE; Noe HN; Wilson EA
    Urology; 1996 Jul; 48(1):119-23. PubMed ID: 8693631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoscopic subureteral glutaraldehyde cross-linked collagen injection for the treatment of secondary vesicoureteral reflux: comparison with primary vesicoureteral reflux in adults.
    Inoue K; Nakamoto T; Usui A; Usui T
    J Urol; 2000 Aug; 164(2):336-9. PubMed ID: 10893579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two differentially structured collagen scaffolds for potential urinary bladder augmentation: proof of concept study in a Göttingen minipig model.
    Leonhäuser D; Stollenwerk K; Seifarth V; Zraik IM; Vogt M; Srinivasan PK; Tolba RH; Grosse JO
    J Transl Med; 2017 Jan; 15(1):3. PubMed ID: 28049497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GAX 65: new injectable cross-linked collagen for the endoscopic treatment of vesicoureteral reflux--a double-blind study evaluating its efficiency in children.
    Frey P; Gudinchet F; Jenny P
    J Urol; 1997 Sep; 158(3 Pt 2):1210-2. PubMed ID: 9258175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the precision of transurethral endoscopic versus ultrasound-guided application of injectables.
    Mitterberger M; Pinggera GM; Pelzer A; Bartsch G; Colleselli D; Neuwirt H; Gradl J; Pallwein L; Aigner F; Frauscher F; Strasser H
    BJU Int; 2008 Jan; 101(2):245-9. PubMed ID: 17922861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term effects of polytetrafluoroethylene injected into the rat bladder submucosa.
    Noe HN; Williams RS; Causey J; Smith DP
    Urology; 1994 Jun; 43(6):852-5; discussion 855-6. PubMed ID: 8197650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary survival studies on autologous cultured skin fibroblasts transplantation by injection.
    Zhao Y; Wang J; Yan X; Li D; Xu J
    Cell Transplant; 2008; 17(7):775-83. PubMed ID: 19044204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term efficacy of subureteral collagen injection for endoscopic treatment of vesicoureteral reflux in neurogenic bladder cases.
    Haferkamp A; Möhring K; Staehler G; Gerner HJ; Dörsam J
    J Urol; 2000 Jan; 163(1):274-7. PubMed ID: 10604375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polyacrylamide Hydrogel as a Bulking Agent for the Endoscopic Treatment of Vesicoureteral Reflux: Long-Term Results and Safety.
    Ramsay S; Blais AS; Morin F; Moore K; Cloutier J; Bolduc S
    J Urol; 2017 Mar; 197(3 Pt 2):963-967. PubMed ID: 27575606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence of autologous free fat transplant in bladder submucosa of rats.
    Matthews RD; Christensen JP; Canning DA
    J Urol; 1994 Aug; 152(2 Pt 2):819-21. PubMed ID: 8022023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Injectable small intestinal submucosa: preliminary evaluation for use in endoscopic urological surgery.
    Furness PD; Kolligian ME; Lang SJ; Kaplan WE; Kropp BP; Cheng EY
    J Urol; 2000 Nov; 164(5):1680-5. PubMed ID: 11025747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A bioactive injectable bulking material; a potential therapeutic approach for stress urinary incontinence.
    Vardar E; Vythilingam G; Pinnagoda K; Engelhardt EM; Zambelli PY; Hubbell JA; Lutolf MP; Frey P; Larsson HM
    Biomaterials; 2019 Jun; 206():41-48. PubMed ID: 30925287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Where should bulking agents for female urodynamic stress incontinence be injected?
    Kuhn A; Stadlmayr W; Lengsfeld D; Mueller MD
    Int Urogynecol J Pelvic Floor Dysfunct; 2008 Jun; 19(6):817-21. PubMed ID: 18157642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mound calcification after endoscopic treatment of vesicoureteral reflux with autologous chondrocytes--a normal variant of mound appearance?
    Gargollo PC; Paltiel HJ; Rosoklija I; Diamond DA
    J Urol; 2009 Jun; 181(6):2702-7; discussion 2707-8. PubMed ID: 19375743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoscopic substances for the treatment of vesicoureteral reflux.
    Joyner BD; Atala A
    Urology; 1997 Oct; 50(4):489-94. PubMed ID: 9338720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term results of endoscopic treatment of vesicoureteral reflux in children: comparison of different bulking agents.
    Stredele RJ; Dietz HG; Stehr M
    J Pediatr Urol; 2013 Feb; 9(1):71-6. PubMed ID: 22212178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.